Covid-19: FDA authorises neutralising antibody bamlanivimab for non-admitted patients
Elisabeth Mahase
Abstract
Covid-19: FDA authorises neutralising antibody bamlanivimab for non-admitted patients
Topics & Concepts
MedicineAuthorizationCoronavirus disease 2019 (COVID-19)Food and drug administrationPlaceboEmergency medicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DrugEmergency department2019-20 coronavirus outbreakIntensive care medicineDiseaseVirologyMedical emergencyInternal medicineInfectious disease (medical specialty)PharmacologyAlternative medicineOutbreakPathologyPsychiatryComputer scienceComputer securityBiomedical Ethics and RegulationPharmaceutical Economics and PolicyImmune responses and vaccinations